Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Orientation and support you will need
  6. Surrogacy (1194)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Surrogacy (1194)

Warning

The Surrogacy Arrangement Act 1985 (amended 1990) defines a surrogate mother as:

“A woman who carries a child in pursuance of an arrangement:

  1. a) Made before she began to carry the child and
  2. b) Made with a view to any child carried in pursuance of it being handed over to, and the parental rights being exercised (so far as is practicable) by another person or persons”.

Types of surrogacy:

  1. Full surrogacy (also known as host or gestational surrogacy) – Where the eggs of the intended mother or donor eggs are used and there is no genetic connection between the baby and the surrogate.
  2. Partial surrogacy (also known as straight or traditional surrogacy) - where the surrogate's eggs are fertilised with the sperm of the intended father.

Who are the mother and father?

The Human Fertilisation and Embryology Act 1990, Section 27, states that the legal mother is always the surrogate mother regardless of genetic makeup and she is legally responsible for the child until such time as the intended parents adopt or seek a parental order made by a family court. Intended parents can start the process to obtain a parental order from six weeks until six months after the birth.

The legal father depends upon other factors:

  • If the surrogate mother is married, then her husband is the legal father.
  • If the surrogate mother has a partner then he is the legal father, unless he can prove that he did not consent to the treatment.
  • If the surrogate mother is single and the treatment did not take place at a centre licensed by the HFEA, then the legal father is the commissioning father.
  • If the surrogate mother is single and the treatment took place in a licensed clinic the child is legally fatherless.

The Department of Health and Social Care (2021) advocates for written surrogacy agreements, ideally prior to conception. Although this is not legally enforceable, it allows the parties to outline management of decision making events and plans for pregnancy, birth and postnatal care of the baby. A surrogacy agreement should be treated by the maternity team with sensitivity and as confidential.

Surrogacy through commercial means is illegal in the UK. Where staff have suspicions that there is a commercial arrangement, they should contact their Lead Midwife for further advice.

  • The surrogate mother may choose to include the intended parent/s in her appointments however, she should be encouraged to have at least one appointment on her own to discuss any confidential medical or personal history and any current concerns.
  • The surrogate should be offered all routine screening tests during pregnancy and it is her decision whether to have them. Results should be directed to her and only shared with the intended parent/s with her consent.
  • With self-insemination there is a risk of transmission of infection to the surrogate and the unborn baby. It is important that she is advised and offered testing. If a transmittable disease is identified, it cannot be shared with the intended parent/s without consent from the surrogate.
  • Community/ named midwife should inform their Team Leader/ Manager of any known surrogacy arrangements. The unit lead midwife and Director of Midwifery should also be informed.
  • Care should be offered to all involved in a non-judgmental and supportive manner.
  • Midwives should ensure that they keep accurate and contemporaneous records of discussions and decisions reached.
  • Confidentiality is vital and disclosure made on a need to know basis. Any reference to the surrogacy arrangement in the medical records should only be made after discussion with and permission from the surrogate mother.
  • The needs of the surrogate mother are always given priority and all (final) decisions rest with her. We would encourage the surrogate mother to be accompanied by partner/ next of kin during delivery.
  • Information to be given to the intended parent/s must be sanctioned verbally by the surrogate mother and documented in the records.
  • The surrogate and intended parent/s should be encouraged to attend at least one appointment together antenatally to identify their plans / wishes with respect to:
    • antenatal screening
    • parenthood preparation
    • birth plan
    • birth partners
    • infant feeding
    • immediate care of baby
    • postnatal visiting / accommodation for the commissioning parents. Intended parent/s will be supported to stay with the baby, ideally in a side room where possible. It should be discussed that limitations within the unit may exist if at capacity and this will be addressed at the time of admission. Consideration should also be given to outline appropriate release of information and intended cares of newborn in the event the surrogate mother is incapacitated immediately post birth. It is important to remember and communicate that legally, intended parents have no legal rights to make decisions for the baby in the immediate post birth period, regardless of biological relationship to child. These conversations should be clearly documented on Badgernet.

  • Where a termination of pregnancy is being considered and the relevant legal conditions are met, the surrogate makes the final decision about a termination. The intended parent/s should be included in any counselling, information sharing and decision making only after the surrogate has given consent.

The surrogate can have up to two birth partners of their choice. This may include having the intended parent/s present for some or all of the labour and birth. Information about the birth should only be given to the intended parent/s with the surrogates consent.

Staff should consider that intended parent/s may feel vulnerable or anxious at this time as they have no legal standing.

During the intrapartum birth plan discussions it is important to consider:

  • If the surrogate wishes to see or touch the baby at birth
  • If the intended parent/s are not present at the birth, when will the baby meet them
  • Who wishes to cut the cord and announce gender
  • Who will give skin to skin contact

The immediate postnatal period is a time of great emotional upheaval, which may be compounded in a surrogacy arrangement and great sensitivity is required in handling both the surrogate and the intended parent/s. Where there is conflict the midwife must focus her care on the surrogate mother and the baby. Seek support from senior Midwifery team in this instance.

  • Usually, the baby will be fully cared for by the intended parent/s from birth and so parenting support, advice and decision making should be directed to them until they and the baby are discharged. It is important that the postnatal ward staff are clear about the wishes of the surrogate and the involvement of the intended parent/s.
  • Wherever possible, surrogates and intended parent/s should be accommodated on the postnatal ward, ideally in separate side rooms and away from other mothers on the ward to maintain privacy at a sensitive time. The need for the baby to be cared for by one or both intended parent/s, should not be limited by normal visiting hours or restrictions on overnight stays.
  • A child born to a surrogate mother must be registered as her child.
  • The surrogate may wish to be discharged independently from the baby. The surrogate mothers care should be transferred to her local community team and she should be cared for as per GGC postnatal care guidelines.
  • Handing over the baby will take place following discussion and agreement with the surrogate mother. The outcome of this discussion and agreement must be documented in the maternal and neonatal Badgernet records.
  • If the baby and surrogate are discharged at different times and the baby is not already being cared for by the intended parent/s, transfer of the baby to the intended parent/s should happen in an appropriate place on the hospital premises. They should not be forced to leave the premises to complete the transfer. Under no circumstances should the baby be discharged with the intended parent/s without the surrogate’s consent. There is no need to inform a social worker or lead for safeguarding unless there are safeguarding concerns.
  • Once discharged, the intended parent/s and baby will require care from the community midwifery team. The ward midwife must ensure the local community team, including the intended parents registered GP, are informed of the birth prior to transfer home. This may be an out of area discharge, so it is vital that during the antenatal period the intended parent/s’ address, telephone number, local hospital and GP details are recorded in the surrogate’s antenatal records.
  • The HFEA advises that, until the parental order comes into force, strictly speaking it is the legal mother who should give consent for any newborn testing. If the baby is discharged with the intended parent/s, there needs to be consent from the surrogate for a healthcare professional to perform screening tests such as the NIPE test, newborn blood spot, hearing test and vaccinations.
  • Where the surrogate has given her consent for the intended parent/s to care for the baby, it is usual practice for the intended parent/s wishes to be considered by staff regarding the treatment of a sick baby. The intended parent/s should be included in any important decisions regarding the health of the baby, whilst recognising that the surrogate has the overall responsibility until a parental order has been issued (British Medical Association, 2008). 
  • The intended parent/s, even if they have taken the child, have no legal relationship with it and no rights in law until a parental order has been made or until the intended father is jointly registered on the birth certificate. Until then, the surrogate mother has legal responsibility for the baby.
  • Intended parent/s will apply for a parental order (if the genetic makeup of baby comes from either or both of them) or an adoption order where gametes from either of the intended parent/s have not been used. Until this time (6 weeks – 6 months) the legal mother is the surrogate mother. In Scotland, having the name of the father on the child’s birth certificate will ensure he has full and equal parental rights and responsibilities.
  • If there are concerns about the welfare of the baby, they should be raised and actioned in accordance with the appropriate safeguarding policies. 

Birth certificate – is issued by the registrar of Births, Deaths and Marriages. Normally the birth of a surrogate baby will be registered by the surrogate herself and her name will be entered as the mother. The person named as father depends upon certain rules contained with the Human Fertilisation and Embryology Act 1990 and the Registration of Births, Deaths and Marriages Scotland Act 1965. Birth father – is the surrogate’s husband unless it can be shown that he did not consent to the surrogacy.

Birth mother – is the legal term for the woman who gives birth to a child as a result of a surrogacy arrangement regardless of whether the child resulted from her egg or not, in accordance with Section 30 of the Human Fertilisation and Embryology Act 1990.

Children (Scotland) Act 1995 – is the main legislation for matters to do with children and families. Its relevance for surrogacy lies mainly in the principle of parental responsibility and in the availability of parental responsibility arrangements.

Intended parent/s – the person/persons who have made an arrangement with a surrogate mother to carry a child for them.

Human Fertilisation and Embryology Act 1990 – for the most part effective from October 1994, this is the main piece of legislation relating to fertility treatment. A Parental Order can be made under S30 of the act effectively transferring rights over the child held by the surrogate (birth) mother at birth to the commissioning parents. The act also provides that the surrogate’s husband is the birth father of the baby unless it can be shown that he did not consent to the surrogacy which the act calls “treatment”.

Surrogacy organisations in the UK:

Brilliant Beginnings - Surrogacy in the UK and abroad

COTS Surrogacy UK | Home

SurrogacyUK

Cafcass

Further Education for staff can be found via the RCM online learning package below:

Surrogacy - Royal College of Midwives

Editorial Information

Last reviewed: 25/03/2025

Next review date: 31/03/2028

Author(s): Nicola O'Brien.

Version: 1

Approved By: Maternity Governance Group

Document Id: 1194